NEO 376

CAS No. 496921-73-4

NEO 376( SPI-376 )

Catalog No. M26328 CAS No. 496921-73-4

NEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 150 In Stock
5MG 136 In Stock
10MG 216 In Stock
25MG 372 In Stock
50MG 512 In Stock
100MG 686 In Stock
200MG 923 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NEO 376
  • Note
    Research use only, not for human use.
  • Brief Description
    NEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.
  • Description
    NEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SPI-376
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Alkyl/ether| PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    496921-73-4
  • Formula Weight
    357.88
  • Molecular Formula
    C20H24ClN3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (349.28 mM)
  • SMILES
    Clc1cccc(c1)N1CCN(CCn2ccc3c2CCCC3=O)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
  • FAUC 346

    FAUC 346 is a highly selective D3 partial agonist with EC50 of 1.5 nM, FAUC 346 with an inhibitory effect on cocaine-seeking behavior.

  • Talquetamab

    Talquetamab (JNJ-64407564) is a GPRC5D bispecific antibody for multiple myeloma (MM) that induces T-cell-mediated killing of GPRC5-expressing MM cells through T-cell recruitment and activation, demonstrating antitumor activity.

  • Veralipride

    Veralipride is an antagonist of D2 receptor.